Latest Updates
Better Blood Transfusion TOOLKIT
Document Library updates
A new page with papers supporting the Change Notifications has been created.
September 2010
Publication of Change Notification 9 & 10 - 2010
June 2010
Publication of Change Notification 6 - 2010
Publication of supporting paper Addition to 14.5.1 of the Red Book to allow rare antisera to be used in investigations.
April 2010
The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated
March 2010
The JPAC Position Statement on West Nile Virus (WNV) has been updated
The JPAC Position Statement on Blood donor selection has been updated
Publication of Change Notification 2 - 5 - 2010
January 2010
The JPAC paper on 'Deviations from 4 oC temperature storage for red cells: Effect on viability and
bacterial growth' is now available as a PDF download from the library page 'General Documents'.
The JPAC paper on 'Validation of Blood Component Quality Following Prion Removal Procedures for Red Cell Components' has been updated 'General Documents'.
Position statement Severe Acute Respiratory Syndrome (SARS) reconfirmed.
Publication of Change Notification 1 - 2010
Publication of supporting paper HbS testing neonatal red cell components
December 2009
Publication of Change Notification 28 - 31 - 2009
Publication of Change Notification 32 - 35 - 2009
November 2009
Commission Directive 2009/135/EC added to EU Directives & Regulations
Publication of Position Statement Chikungunya Virus
Publication of Position Statement Granulocyte Therapy
October 2009
Publication of Change Notification 27 - 2009
Publication of Change Notification 23 - 2009
Publication of Proposal to amend the content of 12.1.4 f) of the 2005 Guidelines.
The JPAC paper on 'The Use of G-CSF in Unrelated Volunteer Stem Cell Donors ' is now available as a PDF download from the library page 'General Documents' has been added.
September 2009
Publication of Change Notification 24 - 26 - 2009
August 2009
Publication of Change Notification 18 - 22 - 2009
July 2009
Publication of Change Notification 17 - 2009
Publication of Change Notification 16 - 2009
June 2009
Publication of Change Notification 12 - 2009
May 2009
Publication of Position Statement Creutzfeldt-Jakob Disease
Publication of Change Notification 8 to 10 & 13 to 15 - 2009
April 2009
Publication of Change Notification 11 - 2009
Pandemic Influenza - The UK Blood Services Plan has been updated.
February 2009
Publication of Change Notifications 03 to 07 - 2009
January 2009
The JPAC Position Statement on Granulocyte Therapy has been updated.
Publication of Change Notifications 01 & 02 - 2009
December 2008
The JPAC paper on 'Recommendations for removal of the upper age limit for regular whole blood and component donors' is now available as a PDF download from the library page 'General Documents' has been updated.
November 2008
The Summary and Report of the JPAC workshop on management of haemoglobin and iron in blood donors are available on this website.
Guidelines for the Blood Services in the UK
June 2010
Change Notification No.6 - 2010
Section 14.5 - Test reagents and test systems
January 2010
Change Notification No.1 - 2010
Section 8.22 - Red Cells for Neonates and Infants, Leucocyte Depleted
Section 8.23 - Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted
October 2009
Change Notification No.23 - 2009
Section 12.1 - Guidelines for reagent manufacture
July 2009
Change Notification No.17 - 2009
Section 8.23 - Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted
Change Notification No.16 - 2009
Section 13.10.7 - Mandatory testing of blood donations
June 2009
Change Notification No.12 - 2009
Section 6.1 - Criteria for acceptance of donors
May 2009
Change Notification No.13 - 2009
Section 4.2 - Responsibility for blood collection
Change Notification No.10 - 2009
Section 22.7 - Testing of deceased donors
Change Notification No.9 - 2009
Section 22.3 - Medical and behavioural history
February 2009
Change Notification No.7 - 2009
Section 8.6 - Red Cells in Additive Solution, Leucocyte Depleted
Section 8.21 - Red Cells for Exchange Transfusion, Leucocyte Depleted
Change Notification No.6 - 2009
Section 8.28 - Irradiated components
Change Notification No.5 - 2009
Chapter 25 – Specification for the uniform labelling of blood and blood components
24.1.4 Referenced documents
25.5 Component labels
Chapter 28 - Specifications for blood pack base labels
28.1 Specification
Change Notification No.4 - 2009
Section 8.8 - Red Cells, Thawed and Washed, Leucocyte Depleted
Change Notification No.3 - 2009
Table 8.20 - Cryoprecipitate, methylene blue treated and removed, leucocyte depleted – additional tests
January 2009
Change Notification No.2 - 2009
Annex 1
Change Notification No.1 - 2009
Section 8.18 - Components Suitable for Use in Intrauterine Transfusion, Neonates and Infants Under One Year
Geographical Disease Risk Index
This page lists all changes to GDRI 001 after Release 01. This page constitutes
Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.
Changes made with Release 10
Changes made to
Greece see Change Notification No. 10 - 2010
Changes made with Release 09
Changes made to
Maldives see Change Notification No. 27 - 2009
Changes made with Release 08
Changes made to
Italy see Change Notification No. 25 - 2009
Canada, United States of America see Change Notification No. 26 - 2009
Changes made with Release 07
Changes made to
Italy see Change Notification No. 11 - 2009
This reverses the changes made with Change Notification No. 05 - 2007.
Changes made with Release 06
This release is the first implementation of the GDRI on the website. Layout and ordering of entries may differ on the website as compared to the Portable Document File (PDF) but there are no changes to the wording of any entries. Consequently no new PDF file is released.
Changes made with Release 05
Errata corrections made to
Italy see Change Notification No. 05 - 2007
Jamaica see Change Notification No. 20 - 2006
Changes made with Release 04
Introduction – Malaria: Airport stopovers see Change Notification No. 15 - 2007
Changes made with Release 03
Bahamas (The) see Change Notification No. 07 - 2007
Canada see Change Notification No. 08 - 2007
United States of America see Change Notification No. 08 - 2007
Changes made with Release 02
Egypt see Change Notification No. 02 - 2007
Ethiopia see Change Notification No. 02 - 2007
Whole Blood and Components
Invalid Link to Page
Bone Marrow and Peripheral Blood Stem Cell
This page lists all changes to TDSG-BM 203 after Release 02.
This pages constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007
Changes introduced with Release 04
Blood Pressure - High See Change Notification No. 1 - 2008
Appendix 4 removed See Change Notification No. 5 – 2008
This update also corrects an error where commas did not display in the A-Z topics content on the website.
Changes introduced with Release 05
Tamiflu® (oseltamivir) See Change Notification No. 30 - 2009
Relenza® (zanamivir) See Change Notification No. 31 - 2009
Changes introduced with Release 06
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009
Changes introduced with Release 07
Body Piercing See Change Notification No. 02 - 2010
Inoculation Injury See Change Notification No. 04 - 2010
Endoscopy See Change Notification No. 05 - 2010
Changes introduced with Release 08
West Nile Virus (WNV) See Change Notification No. 09 - 2010
Cord Blood
This page lists all changes to TDSG-CB 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.
Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007
Changes introduced with Release 04
Tamiflu® (oseltamivir) See Change Notification No. 30 - 2009
Relenza® (zanamivir) See Change Notification No. 31 - 2009
Changes introduced with Release 05
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009
Changes introduced with Release 06
Body Piercing See Change Notification No. 02 - 2010
Endoscopy See Change Notification No. 03 - 2010
Inoculation Injury See Change Notification No. 04 - 2010
Changes introduced with Release 07
West Nile Virus (WNV) See Change Notification No. 09 - 2010
Deceased Donors
This page lists all changes to TDSG-DD 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.
Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed. No other changes where introduced.
Changes introduced with Release 04
Age See Change Notification No. 8 – 2009
Changes introduced with Release 05
Tamiflu® (oseltamivir) See Change Notification No. 28 - 2009
Relenza® (zanamivir) See Change Notification No. 29 - 2009
Changes introduced with Release 06
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009
Changes introduced with Release 07
Body Piercing See Change Notification No. 02 - 2010
Inoculation Injury See Change Notification No. 04 - 2010
Changes introduced with Release 08
West Nile Virus (WNV) See Change Notification No. 09 - 2010
Live Donors
This page lists all changes to TDSG-LD 203 after Release 02. This page constitutes
Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.
Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder
See Change Notification No. 18 - 2007
Changes introduced with Release 04
Tamiflu® (oseltamivir) See Change Notification No. 28 - 2009
Relenza® (zanamivir) See Change Notification No. 29 - 2009
Changes introduced with Release 05
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009
Changes introduced with Release 06
Body Piercing See Change Notification No. 02 - 2010
Endoscopy See Change Notification No. 03 - 2010
Inoculation Injury See Change Notification No. 04 - 2010
Changes introduced with Release 07
West Nile Virus (WNV) See Change Notification No. 09 - 2010